Phathom Pharmaceuticals Sees FY2026 Sales $320.000M-$345.000M vs $314.481M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Phathom Pharmaceuticals (NASDAQ:PHAT) sees FY2026 sales of $320.000 million-$345.000 million vs $314.481 million analyst estimate.
Phathom Pharmaceuticals (NASDAQ:PHAT) sees FY2026 sales of $320.000 million-$345.000 million vs $314.481 million analyst estimate.